| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP, Finance | CFO &Executive Vice President +1 more
5 companies
Sharp Shalini serves as a Director at AGEN and has filed Form 4s across 5 companies. Across recent SEC filings that breaks down to 0 buys and 43 sells. Those positions are worth an estimated $9.1M at current prices.
The biggest single holding is RARE (~$8.6M) as EVP, Finance. The recent filings there lean toward selling, a net 201,572 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 17, 2024 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 1,106 | $141.90 | $156,943.39 | -52.7% | +3.9% | -14.9% | |
| Oct 14, 2020 | RARE Ultragenyx Pharmaceutical Inc. | EVP, Finance | Sell | 375 | $87.99 | $32,996.25 | -0.4% | - | - | |
| Aug 17, 2020 | RARE Ultragenyx Pharmaceutical Inc. | CFO &Executive Vice President | Sale+OE | 14,378 | $88.40 | $1,271,072.70 | -12.8% | - | - | |
| Jun 4, 2020 | RARE Ultragenyx Pharmaceutical Inc. | CFO &Executive Vice President | Sale+OE | 12,798 | $74.19 | $949,431.46 | -11.2% | - | - | |
| May 19, 2020 | RARE Ultragenyx Pharmaceutical Inc. | CFO &Executive Vice President | Sale+OE | 29,113 | $73.33 | $2,134,885.26 | -22.3% | - | - | |
| Mar 18, 2019 | RARE Ultragenyx Pharmaceutical Inc. | CFO &Executive Vice President | Sale+OE | 14,800 | $70.00 | $1,036,000.00 | -18.2% | - | - | |
| Sep 25, 2018 | RARE Ultragenyx Pharmaceutical Inc. | CFO &Executive Vice President | Sale+OE | 6,700 | $90.07 | $603,469.00 | -11.8% | - | - | |
| Jun 7, 2018 | RARE Ultragenyx Pharmaceutical Inc. | CFO &Executive Vice President | Sale+OE | 6,700 | $80.07 | $536,455.60 | -11.1% | - | - | |
| May 30, 2018 | RARE Ultragenyx Pharmaceutical Inc. | CFO &Executive Vice President | Sale+OE | 13,000 | $70.17 | $912,171.00 | -18.5% | - | - | |
| Mar 2, 2017 | RARE Ultragenyx Pharmaceutical Inc. | CFO &Executive Vice President | Sale+OE | 12,000 | $90.10 | $1,081,176.00 | -17.7% | - | - |